Pharmaceuticals Business Investment Opportunity in Pune, India
Manufacturing pharmaceutical products of 1,500 3rd party products and 2 own patented products.
This transaction has concluded.
| Established | 20-30 year(s) |
| Employees | 10 - 50 |
| Legal Entity | General Partnership |
| Reported Sales | USD 1.7 million |
| Run Rate Sales | USD 1.4 million |
| EBITDA Margin | 15 % |
| Industries | Pharmaceuticals |
| Locations | Pune |
| Local Time | 5:52 PM Asia / Kolkata |
| Listed By | Business Owner / Director |
| Status | Active |
Partial Stake Sale
USD
600 thousand
for
30.0%
stake
(Native Currency: INR 50,000,000)
Reason: Has acquired land from MIDC at Rs. 2.25 crore and seeking investment to buy machinery and setup the ...
View More
Includes physical assets worth
USD
1.2 million
Business Overview
- The company manufactures different types of pharmaceutical products.
Projected turnover 50cr.
- Manufactures 1,500+ products for 3rd party and 2 own patented products.
We are with OTC division brand GP ADULSA & more products.
- Serving 200+ clients clients PAN India.
- Planning to start larger manufacturing unit and has already acquired 2 acres of land from MIDC at Rs. 3.5 crore.
- Having GMP & ISO certification.
- Owner has 25+ years of industry experience.
Products & Services Overview
Products like Allopathic (Clavulanic Tablet, capsule, dry injectable, soft gel) Ayurvedic, Nutraceuticals and Cosmetics.
Facilities Overview
Current unit: 20,000 sq ft.
New acquired land from MIDC: 8000 sq. mt.
Capitalization Overview
Not Disclosed
Recent Activity
-
Earlier than 15 daysPartner, Healthcare, Pune, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysDirector - Business Development & Board Member, Pharmaceuticals ( API Mfg & Exports), Mumbai, Corporate Investor / Buyer connected with the Business
-
Earlier than 15 daysPartner, New Delhi, Financial Advisor connected with the Business
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
